Teaching hospital Program year 2025 Source: CMS Open Payments

University of Iowa Hosp & Clinics

IA

CCN 160058 CMS hospital 16122

Open in the dashboard

General payments

$12,982,166

2,905 payments

Research payments

$137,160,644

14,921 payments

Through program year 2025, University of Iowa Hosp & Clinics is reported as receiving $12,982,166 in general payments and $137,160,644 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $2,021,212 467
2025 Research $17,922,946 2,066
2024 General $3,011,175 479
2024 Research $29,655,623 2,413
2023 General $2,300,769 419
2023 Research $20,873,474 2,421
2022 General $1,504,583 261
2022 Research $18,085,224 2,126
2021 General $830,849 262
2021 Research $19,707,266 1,978
2020 General $842,357 332
2020 Research $17,244,408 2,218
2019 General $2,471,221 685
2019 Research $13,671,703 1,699

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $2,254,175 31 payments
  2. Zimmer Biomet Holdings, Inc. $846,269 24 payments
  3. Solventum Corporation $825,788 4 payments
  4. ZOLL Medical Corporation $687,825 18 payments
  5. E.R. Squibb & Sons, L.L.C. $681,290 92 payments
  6. 3M Company $638,774 1 payment
  7. Pfizer Inc. $587,027 97 payments
  8. Intuitive Surgical, Inc. $566,417 65 payments
  9. Intercept Pharmaceuticals, Inc. $407,135 37 payments
  10. Paragon 28, Inc. $358,000 11 payments
  11. Other $5,129,468 2,525 payments
What the payments were for General payments · program years 2019–2025
  1. Grant $6,444,497 276 payments
  2. Space rental or facility fees (teaching hospital only) $1,890,930 1,675 payments
  3. Consulting Fee $1,651,693 138 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,100,657 369 payments
  5. Royalty or License $908,828 119 payments
  6. Long term medical supply or device loan $615,511 136 payments
  7. Education $209,073 102 payments
  8. Debt forgiveness $89,017 45 payments
  9. Gift $40,777 14 payments
  10. Charitable Contribution $25,410 20 payments
  11. Other $5,772 11 payments
Products named General payments · program years 2019–2025
  1. Clarity Aligners $1,363,571 4 payments
  2. General - Erectile Dysfunction $651,960 6 payments
  3. Trabecular Metal (TM) Ankle Foot & Ankle $580,741 8 payments
  4. General - Male Sui $505,360 2 payments
  5. Davinci XI $474,158 56 payments
  6. Ocaliva $407,135 37 payments
  7. Defibrillator $370,723 6 payments
  8. Trabecular Metal (TM) Ankle Foot & Ankle $254,420 3 payments
  9. Valrubicin Intravesical Solution $247,608 13 payments
  10. Invisalign $147,810 2 payments
  11. Other $3,430,324 2,399 payments

A payment can name more than one product, so these amounts overlap.

2,905 general · 14,921 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record